Anti-inflammatory effect of full-length adiponectin and proinflammatory effect of globular adiponectin in esophageal adenocarcinoma cells

Oncology Research

Volumn 21, Issue 1, 2013, Pages 15-21

  Zhang, Rong ^a   Wu, Jie ^a   Liu, Dong ^a   Shan, Hu ^a   Zhang, Jun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Adiponectin; Esophageal adenocarcinoma (EAC); Inflammation; Inflammatory factors

Indexed keywords

ACETYLCYSTEINE; ADIPONECTIN; ANTIINFLAMMATORY AGENT; FULL LENGTH ADIPONECTIN; GLOBULAR ADIPONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL ADENOCARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOCARCINOMA; ADIPONECTIN; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890928557     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13786659070235     Document Type: Article

References (42)

1. Cook, M. B.; Chow, W. H.; Devesa, S. S. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br. J. Cancer 101:855-859; 2009.
2. Holmes, R. S; Vaughan, T. L. Epidemiology and pathogenesis of esophageal cancer. Semin. Radiat. Oncol. 17:2-9; 2007.
3. Thrift, A. P.; Pandeya N.; Whiteman D. C. Current status and future perspectives on the etiology of esophageal adenocarcinoma. Front. Oncol. 2:1-7; 2012.
4. Turati, F.; Tramacere, I.; Vecchia, C. L.; Negri, E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann. Oncol. 00:1-9; 2012.
5. Olsen, C. M.; Pandeya, N.; Green, A. C.; Webb, P. M.; Whiteman, D. C. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am. J. Epidemiol. 174:582-590; 2011.
6. El-Serag, H. B. Role of obesity in GORD-related disorders. Gut 57:281-284; 2008.
7. Wu, A. H.; Tseng, C. C.; Bernstein, L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 98:940-948; 2003.
8. Beddy, P.; Howard, J.; McMahon, C.; Knox, M.; Blacam, C.; Ravi, N.; Reynolds, J. V.; Keogan, M. T. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br. J. Surg. 97:1028-1034; 2010.
9. Chandran, M.; Phillips, S. A.; Ciaraldi, T.; Henry, R. R. Adiponectin: More than just another fat cell hormone? Diabetes Care 26:2442-2450; 2003.
10. Turer, A. T.; Scherer, P. E. Adiponectin: Mechanistic insights and clinical implications. Diabetologia 55:2319-2326; 2012.
11. Waki, H.; Yamauchi, T.; Kamon, J.; Kita, S.; Ito, Y.; Hada, Y.; Uchida, S.; Tsuchida, A.; Takekawa, S.; Kadowaki, T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146:790-796; 2006.
12. Kadowaki, T.; Yamauchi, T. Adiponectin and adiponectin receptors. Endocr. Rev. 26:439-451; 2005.
13. Fruebis, J.; Tsao, T. S.; Javorschi, S.; Ebbets-Reed, D.; Erickson, M. R.; Yen, F. T.; Bihain, B. E.; Lodish, H. F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98:2005-2010; 2001.
14. Ogunwobi, O. O.; Beales, I. L. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol. Cell. Endocrinol. 285:43-50; 2008.
15. Gavrila, A.; Chan, J. L.; Yiannakouris, N.; Kontogianni, M.; Miller, L. C.; Orlova, C.; Orlova, C.; Mantzoros, C. S. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: Cross-sectional and interventional studies. J. Clin. Endocrinol. Metab. 88:4823-4831; 2003.
16. Tilg, H,; Moschen, A. R. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6:772-783; 2006.
17. Ishikawa, M.; Kitayama, J.; Kazama, S.; Hiramatsu, T.; Hatano, K.; Nagawa, H. Plasma adiponectin and gastric cancer. Clin. Cancer Res. 11:466-472; 2005.
18. Otake, S.; Takeda, H.; Suzuki, Y.; Fukui, T.; Watanabe, S.; Ishihama, K.; Saito, T.; Togashi, H.; Nakamura, T.; Matsuzawa, Y.; Kawata, S. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: Evidence for participation of insulin resistance. Clin. Cancer Res. 11:3642-36462; 2005.
19. Yildirim, A.; Bilici, M.; Cayir, K.; Yanmaz, V.; Yildirim, S.; Tekin, S. B. Serum adiponectin levels in patients with esophageal cancer. Jpn. J. Clin. Oncol. 39:92-96; 2009.
20. Miyazaki, T.; Bub, J. D.; Uzuki, M.; Iwamoto, Y. Adiponectin activates c-JunNH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem. Biophys. Res. Commun. 333:79-87; 2005.
21. Mistry, T.; Digby, J. E.; Desai, K. M.; Randeva, H. S. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU Int. 101:1317-1322; 2008.
22. Howard, J. M.; Beddy, P.; Ennis, D.; Keogan, M.; Pidgeon, G. P.; Reynolds, J. V. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br. J. Surg. 97:1020-1027; 2010.
23. Dalamaga, M.; Diakopoulos, K. N.; Mantzoros, C. S. The role of adiponectin in cancer: A review of current evidence. Endocr. Rev. 33:547-594; 2012.
24. Konturek, P. C.; Burnat, G.; Rau, T.; Hahn, E. G.; Konturek, S. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig. Dis. Sci. 53:597-605; 2008.
25. Saxena, A.; Chumanevich, A.; Fletcher, E.; Larsen, B.; Lattwein, K.; Kaur, K.; Fayad, R. Adiponectin deficiency: Role in chronic inflammation induced colon cancer. Biochim. Biophys. Acta 1822:527-536; 2012.
26. Ouchi, N.; Walsh, K. Adiponectin as an anti-inflammatory factor. Clin. Chim. Acta 380:24-30; 2007.
27. Wulster-Radcliffe, M. C.; Ajuwon, K. M.; Wang, J.; Christian, J. A.; Spurlock, M. E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 316:924-929; 2004.
28. Wolf, A. M.; Wolf, D.; Rumpold, H.; Enrich, B.; Tilg, H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 323:630-635; 2004.
29. Ajuwon, K. M.; Spurlock, M. E. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:1220-1225; 2005.
30. Chedid, P.; Hurtado-Nedelec, M.; Marion-Gaber, B.; Bournier, O.; Hayem, G.; Gougerot-Pocidalo, M. A.; Frystyk, J.; Flyvbjerg, A.; Benna, J. E.; Marie, J. C. Adiponectin and Its Globular Fragment Differentially Modulate the Oxidative Burst of Primary Human Phagocytes. Am. J. Pathol. 180:682- 692; 2012.
31. Colleypriest, B. J.; Ward, S. G.; Tosh, D. How does inflammation cause Barrett's metaplasia? Curr. Opin. Pharmacol. 9:721-726; 2009.
32. Dvorakova, K.; Payne, C. M.; Ramsey, L.; Holubec, H.; Sampliner, R.; Dominguez, J.; Dvorak, B.; Bernstein, H.; Bernstein, C.; Prasad, A.; Fass, R.; Cui, H.; Garewal, H. Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin. Cancer Res. 10:2020-2028; 2004.
33. Abdel-Latif, M, M,; Duggan, S.; Reynolds, J. V.; Kelleheretal, K. D. Inflammation and esophageal carcinogenesis. Curr. Opin. Pharmacol. 9:396-404; 2009.
34. Poehlmann, A.; Kuester, D.; Malfertheiner, P.; Guenther, T.; Roessner, A. Inflammation and Barrett's carcinogenesis. Pathol. Res. Pract. 208:269-280; 2012.
35. Santander, S.; Cebrian, C.; Esquivias, P.; Conde, B.; Esteva, F.; Jimenez, P.; Ortego, J.; Lanas, A.; Piazuelo, E. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice. Int. J. Oncol. 40:527-534; 2012.
36. Kyriazi, E.; Tsiotra, P. C.; Boutati, E.; Ikonomidis, I.; Fountoulaki, K.; Maratou, E.; Lekakis, J.; Dimitriadis, G.; Kremastinos, D. T.; Raptis, S. A. Effects of Adiponectin in TNF-α, IL-6, and IL-10 Cytokine Production from Coronary Artery Disease Macrophages. Horm. Metab. Res. 43:537-544; 2011.
37. Tsatsanis, C.; Zacharioudaki, V.; Androulidaki, A.; Dermitzaki, E.; Charalampopoulos, I.; Minas, V.; Gravanis, A.; Margioris, A. N. Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other proinflammatory stimuli. Biochem. Biophys. Res. Commun. 335:1254-1263; 2005.
38. Park, P. H.; McMullen, M. R.; Huang, H.; Thakur, V.; Nagy, L. E. Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-α) expression via ERK1/2 activation and Egr-1 expression: Role of TNF-α in adiponectin-stimulated interleukin-10 production. J. Biol. Chem. 282:21695-21703; 2007.
39. Haugen, F.; Drevon, C. A. Activation of nuclear factor-kappa B by high molecular weight and globular adiponectin. Endocrinology 148:5478-5486; 2007.
40. Ling, T.; Luo, N.; Zhu, X.; Chun, B.; Garvey, W. T.; Fu, Y. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: Differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis 221:66-75; 2012.
41. Geoffrey, G.; Sylvie L.; Jacques P. NF-κB activation by reactive oxygen species: Fifteen years later. Biochem. Pharmacol. 72:1493-1505; 2006.
42. Baeuerle, P. A.; Henkel, T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179; 1994.